139 results
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
11 Sep 18
Departure of Directors or Certain Officers
12:00am
senior healthcare partners. The passion, experience and leadership that Lynn brings will be of great value as we continue to build one of the world’s … in the healthcare sector, advising CEOs and Boards of leading healthcare companies on their most critical strategic, organizational and operational issues
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
13 May 19
Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors
5:12pm
500 healthcare service companies, as well as the commanding general of the 4th Marine Division and the commander of Marine Forces Reserve.
John F … in both the military and in the healthcare fields. His remarkable service to our nation is humbling and his extensive high integrity executive
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
21 Aug 23
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
7:01am
. His substantial financial experience and expertise across the healthcare industry will be a tremendous benefit to Amicus as we move into the next … and healthcare industry both in the U.S. and internationally. Simon most recently served as Chief Financial Officer of Boston-based biotech Albireo
DEFA14A
EX-99.1
FOLD
Amicus Therapeutics Inc
13 May 19
Additional proxy soliciting materials
5:13pm
500 healthcare service companies, as well as the commanding general of the 4th Marine Division and the commander of Marine Forces Reserve.
John F … in both the military and in the healthcare fields. His remarkable service to our nation is humbling and his extensive high integrity executive
PRE 14A
FOLD
Amicus Therapeutics Inc
11 Oct 11
Preliminary proxy
12:00am
affiliated with Frazier Healthcare Ventures(5)
601 Union Street, Suite 3200
Seattle, WA 98101
Entities affiliated with Prospect Venture Partners II, L.P … of 6,866,244 shares held of record by Glaxo Group Limited.
Consists of 2,330,686 shares beneficially owned by Palo Alto Healthcare Master Fund, L.P., 2,612,425
8-K
i5ekka
7 Jan 19
Other Events
7:05am
8-K
y2moe wu8cmd
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
kfhgto37t 837rv
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
ive23k o9jmmtl0v
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
8-K
sf0rhrf twqhy
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.1
dmxd0ufvdb3x rdfu1u
5 Aug 09
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
12:00am
8-K
EX-99.1
og9eo05hs8
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am